hydrazine has been researched along with Atrophy, Muscle in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukasawa, K; Hanada, K; Hayashi, Y; Hinata, H; Hirai, H; Imai, S; Itoh, F; Ohfusa, R; Takayama, K | 1 |
1 other study(ies) available for hydrazine and Atrophy, Muscle
| Article | Year |
|---|---|
Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model.
Topics: Animals; Biological Products; Cachexia; Disease Models, Animal; Hydrazines; Mice; Muscle, Skeletal; Muscular Atrophy; Myostatin; Neoplasms; Oligopeptides; Peptides; Receptors, Ghrelin; Transforming Growth Factors | 2022 |